Skip to main content
. 2013 May 2;134(2):291–303. doi: 10.1093/toxsci/kft104

Fig. 6.

Fig. 6.

Leptin controls BDCM-induced alterations in glycolysis, gluconeogenesis, and lipid metabolism, thus aiding in development of liver injury in NASH. (A) mRNA expressions of liver Glut-1, PFK, and PCK-1 in DIO + BDCM and Leptin KO +BDCM groups. (B) mRNA expressions of liver PGC-1α, SREBP-1c, and PPAR-γ in DIO + BDCM and Leptin KO + BDCM groups. (C) Picro sirius red staining showing micro- and macrovesicular fibrosis (arrow) in DIO + BDCM (panel i) and Leptin KO + BDCM (panel ii) groups. (D) Hematoxylin and eosin staining showing hepatocellular necrosis (arrow) in DIO + BDCM (panel i) and Leptin KO + BDCM (panel ii) groups. (E) Serum ALT and AST enzyme levels in DIO + BDCM and Leptin KO + BDCM groups (n = 4). *p < 0.05 is considered statistically significant.